OpenAlex
PricingAboutJobs
Log inGet started
Work

Early investigational drugs targeting PPAR-α for the treatment of metabolic disease

HTML

Year: 2015
Type: review
Source: Expert Opinion on Investigational Drugs
DOI: 10.1517/13543784.2015.1006359
Authors: Zhong-Min Liu, Miao Hu, Paul Chan, Brian Tomlinson
Institutions: Tongji University, Shanghai East Hospital, Chinese University of Hong Kong, Prince of Wales Hospital, Wan Fang Hospital, Taipei Medical University
Language: English

Topic: Peroxisome Proliferator-Activated Receptors
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: PPARα agonist, fibrates, atherogenic dyslipidemia, insulin resistance, non-alcoholic fatty liver disease, metabolic disorders, drug development, cardiovascular outcomes, liver outcomes
SDG: Good health and well-being

Open Access status: closed

Funders: Abbott Laboratories, Amgen, Pfizer, Merck Sharp and Dohme
OpenAlex ID: W2051656202
FWCI: 0.807
Cites: 78
Cited by: 49
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security